6514 Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial

✍ Scribed by Pavel, M.; Ruszniewski, P.; Lombard-Bohas, C.; Van Cutsem, E.; Luppi, G.; Rougier, P.; Salazar, R.; Hoosen, S.; Cherfi, A.; Yao, J.

• Book ID: 122387546
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 48 KB
• Volume: 7
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/S1359-6349(09)71236-4